Morning Social Media Outlook for Friday Feb 24 (DDD, FXEN, CRM, MAR)
In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.
Provided by Social Market Analytics, here is the morning social media outlook for Friday, February 24.
3D Systems (NYSE: DDD) reported impressive earnings yesterday afternoon, which lead to a rally in the company's stock. The CEO appeared on CNBC's Fast Money last evening and stated that the company's CUBE printer would be out in the second quarter of the year.
FX Energy (NASDAQ: FXEN) rallied tremendously yesterday, as shares traded from below $6 to almost $7 by the end of the day. A bullish post published on Seeking Alpha, combined with increasing oil prices may have led to the gain in shares.
Salesforce (NYSE: CRM) is currently up over 7% on the session. The company reported strong earnings results yesterday, which may have moved shares into positive territory, particularly given short interest in the name.
Marriot (NYSE: MAR) was upgraded by Goldman Sachs today, and its shares have traded up almost 2% on the session. Still, traders may be looking to fade the name as rising gasoline prices pressure the travel industry.
Apple (NASDAQ: AAPL) regains its place at the top of this list. Shares are currently trading above $520, even after the company failed to announce a dividend at its shareholder meeting yesterday.
Vivus (NASDAQ: VVUS) appears on the list for the second day in the row, a near doubling of share prices after a positive FDA panel vote may have fueled chatter on the name.
Chelsea Therapeutics (NASDAQ: CHTP) is up almost 60% on the session after an FDA panel voted 7-4 to recommend the company's new product.
Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.